•  27
    Truer
    Philosophy of Science 55 (4): 583-597. 1988.
    When can one say that a new theory is truer than the old one it contradicts, even though neither is absolutely true? We are primarily concerned with the case in which the conflicting theories offer answers to the same questions, and so we do not introduce considerations of "logical width". We propose that part of the new theory is truer than part of the old one when the former part gets right whatever the latter-part got right while the former does not make any new mistakes. Pragmatic considerat…Read more
  •  17
    Conventions and illocutionary force
    Philosophical Quarterly 22 (88): 215-233. 1972.
  •  4
    Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors
    with J. E. Eckel-Passow, D. H. Lachance, A. M. Molinaro, K. M. Walsh, P. A. Decker, H. Sicotte, M. Pekmezci, T. Rice, M. L. Kosel, Smirnov IV, G. Sarkar, A. A. Caron, T. M. Kollmeyer, C. E. Praska, A. R. Chada, C. Halder, H. M. Hansen, L. S. McCoy, P. M. Bracci, R. Marshall, S. Zheng, G. F. Reis, A. R. Pico, J. C. Buckner, C. Giannini, J. T. Huse, A. Perry, T. Tihan, M. S. Berger, S. M. Chang, M. D. Prados, J. Wiemels, J. K. Wiencke, M. R. Wrensch, and R. B. Jenkins
    Copyright © 2015 Massachusetts Medical Society.BACKGROUND The prediction of clinical behavior, response to therapy, and outcome of infiltrative glioma is challenging. On the basis of previous studies of tumor biology, we defined five glioma molecular groups with the use of three alterations: mutations in the TERT promoter, mutations in IDH, and codeletion of chromosome arms 1p and 19q. We tested the hypothesis that within groups based on these features, tumors would have similar clinical variabl…Read more